REPLIGUT

Welcome to the Brand page for “REPLIGUT”, which is offered here for Platform, plates having multi-well arrays that can be used for the testing of human and animal intestinal epithelial cells for compound screening, medical research, and disease modeling, not for medical diagnostic or treatment purposes;platform, plates having multi-well arrays that can be used for the testing of human and animal intestinal epithelial cells for compound screening and disease modeling for medical diagnostic and treatment purposes;medical research, drug discovery research, in the field of screening human and animal intestinal epithelial cells for compound screening, disease modeling, medical research, and microbiome research;.

Its status is currently believed to be active. Its class is unavailable. “REPLIGUT” is believed to be currently owned by “Altis Biosystems, Inc.”